|
2024
|
P/S
|
Pharmaceutical products, namely, blood products in the nature of proteins and protein preparation... |
|
|
P/S
|
Pharmaceuticals, Medical Preparations, Especially: Serum preparations, in particular serum protei... |
|
|
Invention
|
Method of manufacturing an igm containing composition. Provided is a method of manufacturing an I... |
|
|
P/S
|
Chemical products for use in industry and science;
biological preparations for use in industry a... |
|
|
P/S
|
Chemical preparations for supplementation of fibrinogen, not for medical or veterinary use; biolo... |
|
|
P/S
|
Biological preparations for use in industry and science, namely proteins and protein preparations... |
|
2023
|
P/S
|
Chemical products for commercial or scientific purposes; biological agents for commercial and sci... |
|
|
P/S
|
Pharmaceutical preparations; medical and veterinary drugs;
blood for medical applications; blood... |
|
2022
|
P/S
|
Pharmaceutical products, medical preparations; Pharmaceutical products, medical preparations, nam... |
|
|
Invention
|
Treatment of severe community acquired pneumonia. The present invention provides for a new therap... |
|
|
Invention
|
Fibrinogen compositions and methods of preparation.
The present invention relates to the field o... |
|
|
Invention
|
Fibrinogen compositions and methods of preparation. The present invention relates to the field of... |
|
|
Invention
|
Dry heat treatment of plasma-derived factor viii. A method of manufacturing a lyophilized plasma-... |
|
|
P/S
|
Biological preparations for use in industry and science, namely, proteins and protein preparation... |
|
2021
|
Invention
|
Method and kit for testing immunomodulatory potency of immunoglobulin compositions for treatment ... |
|
|
Invention
|
Method and kit for testing immunomodulatory potency of immunoglobulin compositions, e.g., for tre... |
|
|
P/S
|
Pharmaceutical products and medical products, namely blood for medical purposes; medical preparat... |
|
|
P/S
|
Pharmaceutical products, medical products, namely, blood
products, medical preparations; in part... |
|
|
Invention
|
Protein comprising at least one regulatory t cell activating epitope.
The present invention rela... |
|
|
Invention
|
Protein comprising at least one regulatory t cell activating epitope. The present invention relat... |
|
|
P/S
|
Pharmaceutical preparations, Medicinal products, Medical preparations; In particular blood prepar... |
|
|
P/S
|
Pharmaceutical products, medical products, namely, blood products, medical preparations; in parti... |
|
|
Invention
|
Subcutaneous administration of factor viii.
The present invention relates to the treatment of he... |
|
|
Invention
|
Subcutaneous administration of factor viii. The present invention relates to the treatment of hem... |
|
|
Invention
|
Methods of treating viral infections by administering an antibody preparation comprising igg, iga... |
|
|
P/S
|
Pharmaceutical products, namely, blood products, in the nature of proteins and protein preparatio... |
|
2020
|
Invention
|
Method for manufacturing a fibrinogen preparation.
A method for manufacturing a fibrinogen prepa... |
|
|
Invention
|
Method for manufacturing a fibrinogen preparation. The invention is concerned with manufacturing ... |
|
|
Invention
|
Factor viii protein with increased half-life. The present invention relates to recombinant coagul... |
|
|
P/S
|
Medical preparations and substances for diagnostic kits,
namely, buffer, salts, solvents and rea... |
|
|
Invention
|
Method and kit for testing potency of immunoglobulin compositions. The present invention relates ... |
|
|
Invention
|
Single chain factor viii molecule.
The present invention relates to a recombinant Factor VIII pr... |
|
|
Invention
|
Single chain factor viii molecule. The present invention relates to a recombinant Factor VIII pro... |
|
|
P/S
|
Pharmaceutical preparations, medical preparations; Blood products, serum preparations; serum prot... |
|
2019
|
P/S
|
Pharmaceuticals, Medical preparations, Especially: Serum preparations, in particular serum protei... |
|
|
Invention
|
De-immunized factor viii molecule and pharmaceutical compositions comprising the same. The presen... |
|
|
Invention
|
De-immunized factor viii molecule and pharmaceutical compositions comprising the same. The ... |
|
2018
|
Invention
|
Combination of anti-il10 and anti-pd1 antibodies in cancer treatment. The present disclosure rela... |
|
|
Invention
|
Igg, iga and igm antibody preparations, method of making and method of use in treatment. An antib... |
|
2017
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical preparations, In particular preparations for treating or preventing rabies infecti... |
|
|
Invention
|
Process for preparing immunoglobulin compositions. Described is a process for the preparation of ... |
|
|
Invention
|
Treatment of severe community acquired pneumonia.
The present invention provides for a new thera... |
|
2016
|
Invention
|
Antibody preparations. An antibody preparation suitable for intravenous administration in humans ... |
|
|
Invention
|
Immunoconjugates targeting cd138 and uses thereof.
Disclosed are immunoconjugates having in part... |
|
2015
|
Invention
|
Agents targeting cd138 and uses thereof.
Disclosed is a human murine chimeric antibody which sub... |
|
|
Invention
|
Use of antibodies for detection of il-10. Provided is a humanized or chimeric antibody or fragmen... |
|
2014
|
Invention
|
Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle). Provided... |
|
|
Invention
|
Immunoconjugates targeting syndecan-1 expressing cells and use thereof.
Immunoconjugates compris... |
|
2012
|
Invention
|
Uses of immunoconjugates targeting cd138. Provided is a method for treating a disease associated ... |
|
|
Invention
|
Process for preparing an immunoglobulin composition. A process is provided for the preparation of... |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of infectious diseases; Pharmaceutic... |
|
2011
|
Invention
|
Igm antibody preparations. Provided is an antibody preparation suitable for intravenous administr... |
|
|
Invention
|
Process for preparing an immunoglobulin composition. Provided is a process for the preparation of... |
|
|
Invention
|
Antibody preparations. Provided is an antibody preparation suitable for intravenous administratio... |
|
|
Invention
|
Composition for treating disease.
The present invention provides pharmaceutical compositions and... |
|
2010
|
Invention
|
Humanized anti-il 10 antibodies for the treatment of systemic lupus erythematosus (sle). Provided... |
|
2005
|
P/S
|
Chemicals used in industry and science; in-vitro diagnostics for industrial and scientific purpos... |
|
|
P/S
|
Pharmaceutical products. |
|
2004
|
P/S
|
Pharmaceutical and veterinary preparations; pharmaceuticals, therapeutic preparations, diagnostic... |
|
2001
|
P/S
|
Chemicals used in industry and science; in-vitro diagnostic preparations for use in industry, med... |
|
|
P/S
|
Intravenously applicable therapeutic preparations. |
|
|
P/S
|
Blood coagulation preparations. |
|
|
P/S
|
Blood coagluation preparations. |
|
|
P/S
|
Intravenous applicable pharmaceuticals. |
|
2000
|
P/S
|
Blood clotting preparation. |
|
1999
|
P/S
|
Injectable pharmaceutical gammaglobuline preparations. |
|
1994
|
P/S
|
Haemostatic products. |
|
1984
|
P/S
|
Pharmaceutical preparations of gamma globulin for injection. |
|
|
P/S
|
Immunoglobulins in the form of injections used for hepatitis
B prophylaxis for delivery to clini... |
|
|
P/S
|
Immunoglobulin. |
|
|
P/S
|
Produits pharmaceutiques, à savoir immunoglobulines pour la
prophylaxie et la thérapie des infec... |
|
1978
|
P/S
|
Chemical products used for medicinal scientific purposes for the determination of blood propertie... |
|
1970
|
P/S
|
Produits chimiques pour la science, à savoir réactifs
destinés à des buts chimiques-médicaux, y ... |
